Caris Life Sciences Partners with Beat Childhood Cancer Research Consortium to Advance Precision Oncology

Caris Life Sciences® (Caris), a forefront AI TechBio company and precision medicine trailblazer, has announced an ongoing partnership with the Beat Childhood Cancer Research Consortium. This consortium, based at Penn State College of Medicine, comprises over 50 universities and children's hospitals, offering a global network of pediatric cancer clinical trials. As part of this collaboration, Caris serves as the molecular analysis partner for the consortium's studies, providing comprehensive genomic, transcriptomic, and proteomic profiling through its molecular profiling capabilities. This partnership aims to enhance precision oncology and biomarker-driven research, facilitating optimized therapeutic options for children with cancer treated at member hospitals, including Penn State Health Children’s Hospital.